FORTRESS BIOTECH INC - COM (FBIO) Institutional Ownership

CUSIP: 34960Q109

13F Institutional Holders and Ownership History from Q1 2015 to Q2 2024

Type / Class
Equity / COM
Symbol
FBIO on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 34960Q109?
CUSIP 34960Q109 identifies FBIO - FORTRESS BIOTECH INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of FORTRESS BIOTECH INC - COM (FBIO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q2 0 $0 -$42,006 0
2024 Q1 144,700 $42,006 +$42,006 $0.29 1
2023 Q4 0 $0 -$5,746,547 0
2023 Q3 19,809,063 $5,749,187 -$2,025,532 $0.29 43
2023 Q2 24,149,052 $13,278,866 -$3,435,262 $0.55 46
2023 Q1 28,425,069 $23,306,552 +$426,105 $0.82 51
2022 Q4 27,497,866 $18,009,174 -$2,026,397 $0.66 47
2022 Q3 29,999,838 $25,794,770 -$780,486 $0.86 56
2022 Q2 30,820,541 $25,882,668 -$4,832,922 $0.84 60
2022 Q1 35,590,426 $48,404,672 +$4,121,988 $1.36 77
2021 Q4 31,748,690 $79,363,187 +$4,365,775 $2.50 78
2021 Q3 30,257,618 $97,454,567 +$678,828 $3.22 76
2021 Q2 30,005,418 $107,116,199 -$4,495,832 $3.57 81
2021 Q1 31,269,164 $110,368,273 -$2,163,672 $3.53 81
2020 Q4 31,890,183 $101,129,398 +$3,026,700 $3.17 84
2020 Q3 26,981,923 $108,992,555 +$32,990,008 $4.04 75
2020 Q2 22,594,538 $60,554,070 +$36,623,387 $2.68 72
2020 Q1 9,185,993 $17,362,233 +$4,224,635 $1.89 53
2019 Q4 6,851,537 $17,601,676 +$2,462,168 $2.57 51
2019 Q3 6,597,888 $9,303,785 +$551,462 $1.41 47
2019 Q2 6,173,403 $9,260,643 -$717,092 $1.50 43
2019 Q1 6,540,627 $11,626,335 -$599,189 $1.78 45
2018 Q4 7,101,953 $6,106,878 -$1,704,990 $0.86 52
2018 Q3 8,435,451 $13,710,475 +$747,616 $1.60 60
2018 Q2 7,590,340 $22,619,672 +$1,930,311 $2.98 60
2018 Q1 6,725,902 $30,597,084 +$3,327,243 $4.55 63
2017 Q4 6,011,485 $23,983,540 -$419,665 $3.99 57
2017 Q3 6,102,536 $26,970,611 -$41,765 $4.42 57
2017 Q2 6,055,749 $28,759,670 -$1,825,981 $4.75 51
2017 Q1 6,471,919 $23,954,770 +$5,169,931 $3.70 46
2016 Q4 6,700,655 $18,090,596 +$150,510 $2.70 48
2016 Q3 7,144,872 $21,205,247 -$2,818,332 $2.97 49
2016 Q2 8,115,211 $21,828,409 +$4,594,100 $2.69 51
2016 Q1 6,354,669 $19,694,000 +$103,657 $3.10 44
2015 Q4 6,377,107 $17,790,000 -$2,374,447 $2.79 40
2015 Q3 7,148,157 $18,583,000 -$3,669,924 $2.60 38
2015 Q2 8,477,290 $28,484,000 +$28,256,231 $3.36 40
2015 Q1 67,761 $261,000 +$261,000 $3.87 2